Ertapenem Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-199

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ertapenem (NDC 25021-199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Ert04 0000 01)

Chemical structure diagram of Ertapenem Sodium, an antibiotic active ingredient. The structure shows the core beta-lactam ring, side chains, and sodium salt form.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Ert04 0000 02)

Ertapenem for Injection 1 gram per vial powder label from Sagent Pharmaceuticals. The label indicates the product is for intravenous or intramuscular use, single-dose, preservative-free and sterile. It includes dosing and reconstitution instructions with storage recommendations, and features the NovaPlus logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.